Clinuvel Pharmaceuticals (UR9A.F) Q1 2024 Earnings

22FebConfirmed
Q3 2022
Q1 2023
Q3 2023
Q1 2024
0.13
0.16
0.19
0.22

Details

Expected EPS
N/A
Actual EPS
0.127228951899
Surprise EPS
0.13
Surprise Percent
+∞%

Description

Clinuvel Pharmaceuticals (UR9A.F) has reported earnings of 0.127228951899 per share for Q1 2024.

0 Comments

Share your thoughts